» Articles » PMID: 17014654

Successful Treatment of Pediatric Psoriasis with Indigo Naturalis Composite Ointment

Overview
Publisher Wiley
Specialties Dermatology
Pediatrics
Date 2006 Oct 4
PMID 17014654
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The treatment of psoriasis in children is still an intractable problem and demands a long-term therapy with prolonged efficacy that is free from serious adverse events. Many modes of therapy are currently in use but the disease is often resistant to treatment owing to the unacceptable toxicity that leads to poor compliance. Therefore, to develop an alternative treatment is indispensable. Traditional Chinese medicine has been documented for over 1000 years to provide various effective treatments for inflammatory skin diseases. Herein, we report an 8-year-old boy with recalcitrant pediatric psoriasis who, after multiple treatment failures with conventional antipsoriatic medications, showed remarkable clinical improvement with 8 weeks of topical treatment with Indigo naturalis composite ointment. Remission has lasted for over 2 years until now. Our patient's response suggests that topical Indigo naturalis composite ointment may provide a safe and effective alternative treatment for pediatric psoriasis.

Citing Articles

Tanshinone IIA, a component of the self-made Xiao-Yin decoction, ameliorates psoriasis by inhibiting IL-17/IL-23 and PTGS2/NF-κB/AP-1 pathways.

Fu L, Li M, Wang P, Chen L, Huang J, Zhang H Skin Res Technol. 2024; 30(2):e13577.

PMID: 38284293 PMC: 10823401. DOI: 10.1111/srt.13577.


Psoriasis Patients with Specific HLA-Cw Alleles and Lower Plasma IL-17 Level Show Improved Response to Topical Lindioil Treatment.

Lin Y, Wang C, Huang Y, Chang Y, Chen C, Wang C Pharmgenomics Pers Med. 2022; 15:515-524.

PMID: 35592551 PMC: 9113440. DOI: 10.2147/PGPM.S351452.


From natural dye to herbal medicine: a systematic review of chemical constituents, pharmacological effects and clinical applications of indigo naturalis.

Qi-Yue Y, Ting Z, Ya-Nan H, Sheng-Jie H, Xuan D, Li H Chin Med. 2020; 15(1):127.

PMID: 33317592 PMC: 7734464. DOI: 10.1186/s13020-020-00406-x.


'Psoriasis 1' reduces psoriasis‑like skin inflammation by inhibiting the VDR‑mediated nuclear NF‑κB and STAT signaling pathways.

Sun W, Gao Y, Yu X, Yuan Y, Yi J, Zhang Z Mol Med Rep. 2018; 18(3):2733-2743.

PMID: 30015892 PMC: 6102645. DOI: 10.3892/mmr.2018.9262.


Psoriasis therapy by Chinese medicine and modern agents.

Meng S, Lin Z, Wang Y, Wang Z, Li P, Zheng Y Chin Med. 2018; 13:16.

PMID: 29588654 PMC: 5865286. DOI: 10.1186/s13020-018-0174-0.